- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03911947
Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure
January 13, 2021 updated by: Aidos Konkayev, Astana Medical University
Assessing the Ventilatory Parameters in Patients With Acute Respiratory Failure After Vibroacoustic Pulmonary Therapy.
Evaluation of the effectiveness of vibroacoustic therapy in the complex treatment of acute respiratory failure
Study Overview
Detailed Description
Assessing the dynamics of changes in physical, instrumental and laboratory parameters in patients with acute respiratory failure taken in the study according to the inclusion criteria and comparing the results with the control group, studying the effectiveness of vibroacoustic lung therapy.
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Almaty, Kazakhstan, 050000
- City clinical hospital №7
-
Astana, Kazakhstan, 010000
- City Clinical Hospital №1
-
Astana, Kazakhstan, 010000
- National Cardiac Surgery Center
-
Astana, Kazakhstan, 010000
- Scientific Research Institute of Traumatology and Orthopedics
-
Shymkent, Kazakhstan, 160000
- Regional cardiology center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adults
- P/F less 300 torr
- ARDS by Berlin convention
Exclusion Criteria:
- children
- acute stroke
- acute coronary syndrome
- DVT
- implanted pacemaker
- rib fracture
- infection on chest
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: SaO2 (oxygen status)
Measurment 4 times per day, ABA (acid-bases analyses)
|
Device for vibroacoustic respiratory therapy
|
ACTIVE_COMPARATOR: PaO2/FiO2 (respiratory index)
Measurment 4 times per day, ABA (acid-bases analyses)
|
Device for vibroacoustic respiratory therapy
|
ACTIVE_COMPARATOR: AB (actual bicarbonat level)
Measurment 4 times per day, ABA (acid-bases analyses)
|
Device for vibroacoustic respiratory therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of time spent on ventilation
Time Frame: 1-2 days
|
Changing of the time spent by patients on mechanical ventilation
|
1-2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 2, 2019
Primary Completion (ACTUAL)
April 30, 2020
Study Completion (ACTUAL)
July 31, 2020
Study Registration Dates
First Submitted
April 8, 2019
First Submitted That Met QC Criteria
April 9, 2019
First Posted (ACTUAL)
April 11, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 14, 2021
Last Update Submitted That Met QC Criteria
January 13, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1972
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
Poitiers University HospitalRecruitingAcute Respiratory Failure | Hypoxemic Respiratory FailureFrance
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Hemovent GmbHMAXIS Medical, LLCActive, not recruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory FailureGermany
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Siriraj HospitalRecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
-
University Hospital, AngersNot yet recruitingCardio-Respiratory FailureFrance
-
University Hospital, MotolCompletedRefractory Respiratory FailureCzechia
Clinical Trials on Vibrolung
-
Astana Medical UniversityCompletedCOVID-19 | Acute Respiratory Failure | Vibration; ExposureKazakhstan
-
Astana Medical UniversityUnknownRespiratory Distress Syndrome | HypoxemiaKazakhstan
-
Bark Technology LLPRecruitingCardiac Surgical Patients (CABG,Mammary Coronary Bypass Surgery,Plastic and Replacement of Valves, Atrial Septal Defect,Ventricular Septal Defect)Kazakhstan